Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - NUTRA PHARMA CORPFinancial_Report.xls
EX-31.1 - NUTRA PHARMA CORP. - NUTRA PHARMA CORPex31_1.htm
10-Q - NUTRA PHARMA CORPfwdnutrapharmas10q.htm

Exhibit 32.1
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report of Nutra Pharma Corp., (the "Company") on Form 10-Q for the quarterly period ended March 31, 2014, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Rik J Deitsch, the Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Dated: May 20, 2014
       
         
/s/ Rik J. Deitsch
       
Rik J. Deitsch
       
Chief Executive Officer and Chief Financial Officer